Publication number: 20130072518
Abstract: The present invention relates to novel bicyclic compounds of the formula (I), and their derivatives, prodrugs, tautomers, stereoisomers, polymorphs, solvates, hydrates, metabolites, N-oxides, pharmaceutically acceptable salts and compositions containing them. The present invention also relates to a process for the preparation of above said novel compounds, and their derivatives, prodrugs, tautomers, stereoisomers, polymorphs, solvates, hydrates, metabolites, N-oxides, pharmaceutically acceptable salts and compositions containing them. These compounds are useful in the treatment and prevention of various disorders that are related to ?4?2 nicotinic receptors.
Type:
Application
Filed:
December 31, 2009
Publication date:
March 21, 2013
Applicant:
Suven Life Science Limited
Inventors:
Ramakrishna Nirogi, Abdul Rasheed Mohammed, Srinivas Veeramalla, Srinivasa Rao Ravella, Ishtiyague Ahmad, Pradeep Jayarajan, Anil Karbhari Shinde, Rama Sastri Kambhampti, Gopinadh Bhyrapuneni, Venkateswarlu Jasti
Patent number: 8273341
Abstract: The invention is related to anti-viral compounds, compositions containing such compounds, and therapeutic methods that include the administration of such compounds, as well as to processes and intermediates useful for preparing such compounds.
Type:
Grant
Filed:
November 8, 2011
Date of Patent:
September 25, 2012
Assignee:
Gilead Sciences, Inc.
Inventors:
Hongyan Guo, Darryl Kato, Thorsten A. Kirschberg, Hongtao Liu, John O. Link, Michael L. Mitchell, Jay P. Parrish, Michael Graupe, Jianyu Sun, James Taylor, Elizabeth M. Bacon, Eda Canales, Aesop Cho, Choung U. Kim, Jeromy J. Cottell, Manoj C. Desai, Randall L. Halcomb, Evan S. Krygowski, Scott E. Lazerwith, Qi Liu, Richard Mackman, Hyung-Jun Pyun, Joseph H. Saugier, James D. Trenkle, Winston C. Tse, Randall W. Vivian, Scott D. Schroeder, William J. Watkins, Lianhong Xu